AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM)

Market Open
11 Aug, 17:58
AMEX AMEX
$
0. 26
-0.01
-2.7376%
$
921.68K Market Cap
- P/E Ratio
- Div Yield
764,969 Volume
- Eps
$ 0.26
Previous Close
Add Transaction
Day Range
0.25 0.26
Year Range
0.21 2.89
Want to track AIM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sovereign Metals upgrades Kasiya resource estimate by 32% ahead of feasibility study

Sovereign Metals upgrades Kasiya resource estimate by 32% ahead of feasibility study

The Malawi-based miner's flagship deposit remains the world's largest natural rutile reserve Sovereign Metals Ltd (ASX:SVM, OTCQX:SVMLF, AIM:SVML, FRA:SVM), the AIM-listed critical minerals company, has significantly upgraded the resource estimate for its Kasiya project in Malawi, sending shares up 9% to 44p. The updated mineral resource estimate (MRE) shows measured and indicated contained rutile rising 32% to 16.1 million tonnes, covering 1.65 billion tonnes of ore graded at 0.98% rutile.

Proactiveinvestors | 4 months ago
Tower Resources raises £1.5m as key project advance

Tower Resources raises £1.5m as key project advance

Tower Resources PLC (AIM:TRP, FRA:ULF1) has raised £1.5 million of new funding to repay a bridge loan as it approaches long-awaited farm-out approvals in Cameroon and Namibia, which could clear the way for the group's next operational steps in both markets. The AIM-listed Africa-focused oil and gas company said Cameroon's state oil company SNH has told it it will recommend both a one-year extension of the Thali licence to March 2027 and approval for Prime Global Energies to acquire a 42.5% stake in the licence, though Tower is still waiting for written confirmation.

Proactiveinvestors | 4 months ago
Helix Exploration takes tangible step towards production as US helium supply squeeze continues

Helix Exploration takes tangible step towards production as US helium supply squeeze continues

HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) has secured its first helium transport trailer, a practical step toward commercial production at its Rudyard project in Montana as disruption in Qatar squeezes global supply. The AIM-listed group told investors it has signed a lease for a ten-cylinder jumbo tube trailer with capacity to carry 156,300 standard cubic feet of compressed helium at a working pressure of 2,669 PSI.

Proactiveinvestors | 5 months ago
Allergy Therapeutics peanut vaccine shows strong immune response in early trial

Allergy Therapeutics peanut vaccine shows strong immune response in early trial

AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed allergy immunotherapy company, has reported positive biomarker results from its PROTECT Phase I/IIa trial of VLP Peanut, a virus-like particle (VLP) vaccine designed to treat peanut allergy. The data showed a strong and consistent immune response across all trial participants, with higher doses associated with greater reductions in basophil sensitivity, a measure of how reactive immune cells are to allergens.

Proactiveinvestors | 5 months ago
Buccaneer Energy seals funding as it looks to boost oil production

Buccaneer Energy seals funding as it looks to boost oil production

Buccaneer Energy Plc (AIM:BUCE, FRA:LMU1) confirmed to investors it has closed a £350,000 fundraise to finance an adjacent producing-well acquisition in East Texas and push ahead with an Organic Oil Recovery (OOR) programme that it says has already doubled output in a pilot area. The AIM-quoted group issued new shares priced at 0.01p, with participation from institutional investor Premier Miton, alongside directors, management and existing shareholders.

Proactiveinvestors | 5 months ago
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes

Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes

The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed biotechnology company specialising in allergy treatments, said it would present positive clinical and safety data from across its research portfolio at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Philadelphia. The company's flagship grass pollen treatment, Grass MATA MPL, delivered a statistically significant 22.5% improvement in a combined symptom and medication score compared with placebo across two phase III clinical trials.

Proactiveinvestors | 5 months ago
TomCo Energy agrees new Valkor deal and raises some working capital, shares drop

TomCo Energy agrees new Valkor deal and raises some working capital, shares drop

TomCo Energy PLC (AIM:TOM, OTC:TMCGF) shares dropped 35% on Monday, falling to 0.035p, impacted by expected new equity dilution, after it announced a renewed partnership with Valkor LLC that leaves the pair jointly controlling Greenfield Energy on a 50:50 basis, as the AIM-listed group looks to progress oil-sands opportunities in Utah's Uinta Basin. The reset comes with balance-sheet engineering.

Proactiveinvestors | 5 months ago
Rome Resources unearths "exciting new areas" for tin and copper at Mont Agoma

Rome Resources unearths "exciting new areas" for tin and copper at Mont Agoma

Rome Resources Plc (AIM:RMR, FRA:33R) has sharpened drill targeting at its Mont Agoma prospect in the Democratic Republic of Congo after a new geological interpretation outlined fresh, high-priority zones for both tin and copper beyond the current footprint. The AIM-listed explorer said specialist consultancy Chemostrat reworked its geological and assay database and identified a marker horizon above “Zone 3” that better predicts where mineralisation sits, splitting the sequence into five zones.

Proactiveinvestors | 5 months ago
Seeing Machines flags second-half profit as EU car safety deadline nears

Seeing Machines flags second-half profit as EU car safety deadline nears

Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z), the AIM-listed computer vision technology company, said it expected automotive production volumes to “increase materially” in the coming quarters as the EU's General Safety Regulation deadline approaches. In the update, it also forecast positive adjusted earnings before interest, tax, depreciation and amortisation in the third quarter and the second half of its financial year.

Proactiveinvestors | 5 months ago
Cora Gold shares fall 12% after it unveils fundraiser for Mali project

Cora Gold shares fall 12% after it unveils fundraiser for Mali project

Shares in West African explorer Cora Gold Ltd (AIM:CORA, FRA:C0J) dropped sharply after the company secured up to £15.7 million in new funding to advance its flagship mine in Mali towards production. Cora, which trades on London's AIM market, announced it had raised a minimum of £12.9 million and up to £13.7 million through a subscription led by Singapore-based investor Eagle Eye Asset Holdings.

Proactiveinvestors | 6 months ago
Are Medical Stocks Lagging AIM ImmunoTech (AIM) This Year?

Are Medical Stocks Lagging AIM ImmunoTech (AIM) This Year?

Here is how AIM ImmunoTech Inc. (AIM) and Cullinan Therapeutics (CGEM) have performed compared to their sector so far this year.

Zacks | 6 months ago
KEFI edges higher on Saudi minerals tie-up hopes

KEFI edges higher on Saudi minerals tie-up hopes

Shares in KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF, FRA:KMSA) rose 7% to 1.42p on Friday after the company responded to speculation around a possible new joint venture in Saudi Arabia. The AIM-quoted precious metals group, which is in the mine construction phase in Ethiopia, said its Saudi Gold and Minerals SLA (known as GMCO), in which it holds a 13% stake, is working with local conglomerate AJ Lan Group on a potential deal.

Proactiveinvestors | 6 months ago
Loading...
Load More